Back to Blog
Market Analysis

From Charge Trap to Cure: The AIM2 Therapeutic Pipeline

Mapping the multi-billion dollar market opportunity in SLE, psoriasis, and neurodegenerative disease.

Q-RETIX Research Team

Market Analysis

June 15, 2026
8 min read
From Charge Trap to Cure: The AIM2 Therapeutic Pipeline
Research updates

Follow the work as it develops.

Receive occasional Q-RETIX research articles, transparent product progress, and opportunities to contribute feedback.

Research notes

New articles, methods, and scientific explainers.

Product progress

Transparent updates as research concepts become prototypes.

Early opportunities

Occasional invitations to feedback sessions or beta access.

Join the list

Stay close to the research.

This website does not yet use an automated subscription backend. Use your own email app to request research updates; Q-RETIX receives information only after you choose to send the message.

No personal information is collected by this page. Your email provider handles the message you decide to send. Read the Privacy Policy.

Prefer a direct conversation?

Meet Q-RETIX
No automatic enrollmentNo fabricated success messageResearch communications only